LEN vs TERN
LEN (LEN) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
LEN (LEN) common stock.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
LEN does not have a complete income-statement cache yet.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
LEN currently screens at market cap $0. TERN currently screens at market cap $6.12B.
Not investment advice. Open the LEN and TERN stock pages for the full models.
Not investment advice.